Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
- 14 December 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (24) , 1600-1608
- https://doi.org/10.1056/nejm199512143332404
Abstract
Toxic epidermal necrolysis and Stevens–Johnson syndrome are rare, life-threatening, drug-induced cutaneous reactions. We conducted a case–control study to quantify the risks associated with the use of specific drugs.Keywords
This publication has 32 references indexed in Scilit:
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Pharmaceutical prescriptions in four European countriesThe Lancet, 1993
- CHLORMEZANONE IN PRIMARY FIBROMYALGIA SYNDROME: A DOUBLE BLIND PLACEBO CONTROLLED STUDYRheumatology, 1993
- Systemic hydrocortisone/cortisol induces allergic skin reactions in presensitized subjectsPublished by Elsevier ,1991
- Contact allergy to corticosteroids: A frequently missed diagnosis?Journal of the American Academy of Dermatology, 1989
- Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1989
- Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemiaJournal of the American Academy of Dermatology, 1988
- Pretreatment with Corticosteroids to Alleviate Reactions to Intravenous Contrast MaterialNew England Journal of Medicine, 1987
- Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty casesJournal of the American Academy of Dermatology, 1985
- Etiologic Factors of the Stevens-Johnson SyndromeSouthern Medical Journal, 1980